BridgeBio Pharma, Inc. Long-Term Investments Change (Net)

Long-Term Investments Change (Net) of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-Term Investments Change (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Long-Term Investments Change (Net) for the quarter ending September 30, 2022 was $148 Million (a 238.54% increase compared to previous quarter)
  • Year-over-year quarterly Long-Term Investments Change (Net) increased by 506.57%
  • Annual Long-Term Investments Change (Net) for 2021 was $-166 Million (a 329.38% increase from previous year)
  • Annual Long-Term Investments Change (Net) for 2020 was $-38.7 Million (a -81.82% decrease from previous year)
  • Twelve month Long-Term Investments Change (Net) ending September 30, 2022 was $345 Million (a 15.84% increase compared to previous quarter)
  • Twelve month trailing Long-Term Investments Change (Net) decreased by -307.56% year-over-year
Trailing Long-Term Investments Change (Net) for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$345 Million $298 Million $243 Million $-166 Million
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-Term Investments Change (Net) of BridgeBio Pharma, Inc.

Most recent Long-Term Investments Change (Net)of BBIO including historical data for past 10 years.

Interactive Chart of Long-Term Investments Change (Net) of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Long-Term Investments Change (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $147.62 $43.6 $129.48
2021 $24.34 $100.43 $-10.91 $-280.09 $-166.23
2020 $92.07 $-44.5 $-128.79 $42.5 $-38.72
2019 $-15.15 $-197.75 $-212.9

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology